Recro Pharma shares plummet after FDA rejects non-opioid pain shot
By Sharnya G and Tamara Mathias (Reuters) – Recro Pharma’s shares dropped more than 50...
Read More
Updated
U.S. biotechs to speed work on Nipah vaccine as virus hits India
By Ben Hirschler LONDON (Reuters) – A global coalition set up a year ago to fight epidemics...
Read More
Congo to begin Ebola vaccinations on Monday
By Benoit Nyemba MBANDAKA, Democratic Republic of Congo (Reuters) – Health workers in...
Read More
Congo’s Ebola not an international emergency, can be controlled -WHO
By Tom Miles and Fiston Mahamba GENEVA/KINSHASA (Reuters) – The Ebola outbreak in Democratic...
Read More
Trump proposes taking funds away from abortion providers
By Roberta Rampton WASHINGTON (Reuters) – U.S. President Donald Trump on Friday issued a...
Read More
Regulators flag possible birth defect link to GSK’s HIV drug
By Ben Hirschler LONDON (Reuters) – U.S. and European regulators said they were assessing...
Read More
Big Ag turns to peas to meet soaring global protein demand
By Rod Nickel and P.J. Huffstutter (Reuters) – Cargill, the global grains trader, sees the...
Read More
Agile Therapeutics sinks after FDA feedback on contraceptive
By Tamara Mathias (Reuters) – Agile Therapeutics Inc’s shares sank 75 percent on...
Read MoreReporting outcomes of procedure to unblock arteries may not improve care
By Lisa Rapaport (Reuters Health) – Public reporting of outcomes for a common procedure to clear blocked arteries was supposed to improve quality, but some doctors say it hasn’t delivered on the goal of enhancing...
Read MoreMental health support lacking in U.S. diabetes care
By Mary Gillis (Reuters Health) – Most of the top diabetes treatment centers in the U.S. provide experts in hormonal disease, diet and nutrition and diabetes education as part of normal care, but mental health support is...
Read MoreU.S. FDA approves Amgen drug for prevention of migraines
By Deena Beasley (Reuters) – Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults. The drug, Aimovig, which is given...
Read More
FDA names drugmakers potentially acting to delay cheap generics
By Michael Erman (Reuters) – The U.S. Food and Drug Administration on Thursday listed a...
Read More
Congo and WHO race to prevent runaway Ebola outbreak
By Patient Ligodi and Benoit Nyemba KINSHASA (Reuters) – Congolese and U.N. officials were...
Read More
Merck KGaA’s lung cancer drugs show promise in early-stage trials
By Ludwig Burger FRANKFURT (Reuters) – Germany’s Merck KGaA said two of its...
Read MoreLoxo Oncology’s targeted RET drug shows promise in early trial
By Julie Steenhuysen CHICAGO (Reuters) – An experimental Loxo Oncology Inc drug that targets cancers with mistakes in the RET gene led to tumor shrinkage in nearly 70 percent of patients regardless of where their cancer...
Read More
Congo receives first doses of Ebola vaccine amid outbreak
GENEVA/KINSHASA (Reuters) – The first batch of 4,000 experimental Ebola vaccines to combat...
Read MoreTesting for all lung cancer mutations at once found cost effective – study
By Julie Steenhuysen CHICAGO (Reuters) – Testing advanced lung cancer patients for all of the possible genetic mutations that could be driving their cancer at once is more cost effective than testing for one or a limited...
Read MoreFDA reports inaccuracy in IQVIA opioid sales data
(Reuters) – The U.S. Food & Drug Administration said on Wednesday it found inaccuracies in sales data of opioid drug products provided by IQVIA Holdings Inc, a vendor it contracts. The regulator said IQVIA...
Read More
Sivantos and Widex in $8 billion merger to create No.3 in hearing aids
By Stine Jacobsen and Arno Schuetze COPENHAGEN/FRANKFURT (Reuters) – Hearing aid makers...
Read More
Groups sue to stop Iowa’s ‘fetal heartbeat’ abortion ban
(Reuters) – Planned Parenthood and the American Civil Liberties Union’s Iowa branch...
Read More